Related Experiment Video
Updated: Jul 16, 2025

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.1K
Multidimensional computational study to understand non-coding RNA interactions in breast cancer metastasis
Sohini Chakraborty1, Satarupa Banerjee2
1Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
Scientific Reports
|September 22, 2023
Summary
This study deciphers gene and non-coding RNA interactions in breast cancer metastasis, identifying key networks and transcription factors for potential therapeutic targets. Findings offer insights into complex molecular mechanisms driving cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Metastasis is a critical hallmark of breast cancer, driving disease progression and mortality.
- Understanding the complex molecular interactions underlying metastasis is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the intricate interactions among differentially expressed genes, non-coding RNAs (miRNAs, lncRNAs), and drugs associated with breast cancer metastasis.
- To identify key regulatory networks, hub molecules, and transcription factors involved in breast cancer progression.
Main Methods:
- Construction of gene co-expression, mRNA-miRNA-lncRNA-drug, and mRNA-miRNA-TF interaction networks.
- Analysis of topological parameters, significant cliques, transcription factor (TF) analysis, and TCGA expression data.
- Functional enrichment analysis of differentially expressed genes.
Main Results:
- Identification of significant cliques and hub RNAs within the constructed networks.
- Discovery of two significant transcription factors (EST1 and SP1) associated with breast cancer metastasis.
- TCGA expression, subclass-based, and methylation analyses revealed insights into mRNA and non-coding RNA roles.
Conclusions:
- The identified significant cliques may serve as targets for novel therapeutic interventions in breast cancer.
- This research provides a deeper understanding of the molecular intricacies of breast cancer metastasis, potentially revealing new biomarkers.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

